Pfizer

Extending Antibiotic Donations to Eliminate Trachoma

Article

Pfizer has long been a partner in the global effort to eliminate trachoma, the world’s leading infectious cause of blindness, through its donation of an oral antibiotic that can help treat and prevent the debilitating disease. Now, Pfizer has announced that it will extend its donation of the antibiotic through 2025, building on the company’s 20-year support of a partnership to eliminate this disease.

Tackling Antimicrobial Resistance with The Power of Science

Multimedia with summary

Antimicrobial resistance (AMR), or the ability of a bacterium, virus, or fungus to develop resistance to the medicines commonly used to treat them, is one of the leading global public health threats today. Currently, AMR causes more than 700,000 deaths annually. If left unchecked, this number is expected to rise to 10 million deaths annually by 2050. In collaboration with the infectious disease community, we are working to develop solutions that address and help treat the serious and growing AMR crisis.

The Pfizer Foundation Announces $5 Million Grant to Support Women and Families

Article

The Pfizer Foundation* recently announced a $5 million grant recommitment to initiatives that provide family planning access and education for women and men at the same time children are routinely vaccinated.

By increasing access to these integrated services, we’re helping women access reproductive and sexual health services at the same time their children are vaccinated – and in turn, supporting efforts to improve the health of women and their families by:

Nepal Validated by WHO for Eliminating Blinding Trachoma

Blog

The World Health Organization (WHO) announced today that it has validated Nepal as the sixth country to eliminate trachoma as a public health problem.

Advancing The Power of Science Behind Immuno-Oncology

Multimedia with summary

Pfizer’s advances in oncology demonstrate the Power of Scientific innovation to help improve lives, particularly the power of Immuno-oncology (I-O). Immuno-oncology uses the natural ability of the body’s immune system to recognize and fight tumors. This past year, Pfizer continued to advance its work in I-O because we recognize the urgency of finding anti-cancer alternatives to help patients who need them.

An Intervention That Can Significantly Improve Child Health

Blog

The New England Journal of Medicine has published results from a new study showing that the use of an antibiotic significantly reduced mortality among children living in three low-income countries in Sub-Saharan Africa.

Giving Millions a Shot

Blog

We are proud to work with Gavi, the Vaccine Alliance and the United Nations' (UN) Shot@Life campaign to ensure Pfizer’s life-saving vaccines reach those who need them most.

Pfizer Foundation Continues Support of Local Organizations through 2018 Global Health Innovation Grants

Blog

At Pfizer, we believe that all individuals deserve access to quality healthcare and the opportunity to lead healthy lives. As part of its efforts to support sustainable solutions to improving access to quality healthcare around the world, the Pfizer Foundation provides grant funding and technical support to health-focused entrepreneurs and social enterprises through the Global Health Innovation Grants (GHIG) program.

Using the Power of Partnerships to Support Global Goal 5: Gender Equality

Multimedia with summary

At Pfizer, we are proud to support the United Nations Sustainable Development Goals (SDGs), specifically Goal 5: Gender Equality. Equality across genders is fundamental to advancing all 17 of the SDGs, which in turn is connected to advancing global health.

This year and every year, Pfizer harnesses the power of partnerships with various organizations to help empower and mobilize women in need. 

Pfizer’s 15-Year Legacy of Skills-Based Volunteering Helps Improve Healthcare Capacity Around the World

Article

Fifteen years ago, Pfizer established its skills-based volunteer program that takes a collaborative approach to deliver on its commitment to address pressing health needs in underserved communities around the world. Through this unique initiative, 490 Pfizer colleagues have contributed their diverse expertise and time in 50 countries to work with more than 70 partner organizations on projects aimed at strengthening health systems.

Pages

Subscribe to Pfizer